Stratifying patients at the risk of heart failure hospitalization using existing device diagnostic thresholds

Heart and Lung: Journal of Acute and Critical Care

Volumn 44, Issue 2, 2015, Pages 129-136

  Sharma, Vinod ^a   Rathman, Lisa D ^b   Small, Roy S ^b   Whellan, David J ^c   Koehler, Jodi ^a   Warman, Eduardo ^a   Abraham, William T ^d  

^a MEDTRONIC INC   (United States)

^b LANCASTER GENERAL HOSPITAL   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Ambulatory monitoring; Heart failure; Heart failure hospitalization; Implantable device diagnostics; Intrathoracic impedance

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL OBSERVATION; FEMALE; FOLLOW UP; HEART FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; ATRIAL FIBRILLATION; CARDIOVERSION; HEART RATE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; RISK; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RISK;

EID: 84924530933     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2014.07.007     Document Type: Article

References (41)

1. Hohnloser S.H., Israel C.W. Current evidence base for use of the implantable cardioverter-defibrillator. Circulation 2013, 128:172-183.
2. Goldenberg I., Moss A.J. Implantable device therapy. Prog Cardiovasc Dis 2008, 50:449-474. 10.1016/j.pcad.2007.09.002.
3. Heidenreich P.A., Albert N.M., Allen L.A., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013, 6:606-619.
4. Adamson P.B., Smith A.L., Abraham W.T., et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation 2004, 110:2389-2394.
5. Pressler A., Danner M., Esefeld K., et al. Validity of cardiac implantable electronic devices in assessing daily physical activity. Int J Cardiol 2013, 168:1127-1130.
6. Conraads V.M., Spruit M.A., Braunschweig F., et al. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure. Circ Heart Fail 2014, 7:279-287.
7. Walsh J.T., Charlesworth A., Andrews R., Hawkins M., Cowley A.J. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. Am J Cardiol 1997, 79:1364-1369.
8. Koplan B.A., Kaplan A.J., Weiner S., Jones P.W., Seth M., Christman S.A. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary?. JAm Coll Cardiol 2009, 53:355-360.
9. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005, 112:841-848.
10. Whellan D.J., Ousdigian K.T., Al-Khatib S.M., et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. JAm Coll Cardiol 2010, 55:1803-1810. 10.016/j.jacc.2009.11.089.
11. Sarkar S., Koehler J. Adynamic risk score to identify increased risk for heart failure decompensation. IEEE Trans Biomed Eng 2013, 60:147-150. Epub 2012 Jul 20. 10.1109/TBME.2012.2209646.
12. Sharma V., Sarkar S., Koehler J. Integrated device diagnostics can identify patients at significantly elevated risk of heart failure hospitalization. Heart Rhythm 2012, 9(5). [May Supplement].
13. Abraham W.T., Compton S., Haas G., et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail 2011, 17:51-55. Epub 2011 Mar 21. 10.1111/j.751-7133.2011.00220.x.
14. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. NEngl J Med 2005, 352:1539-1549. Epub 2005 Mar 7.
15. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N.Engl J Med 2004, 350:2140-2150.
16. Gold M.R., Ahmad S., Browne K., Berg K.C., Thackeray L., Berger R.D. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm 2012, 9:370-377.
17. Sarkar S., Koehler J., Crossley G.H., et al. Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization. Am Heart J 2012, 164:616-624.
18. Perego G.B., Landolina M., Vergara G., et al. Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization. JInterv Card Electrophysiol 2008, 23:235-242.
19. Ousdigian K.T., Borek P.P., Koehler J.L., Heywood J.T., Ziegler P.D., Wilkoff B.L. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 2014, 7:370-376.
20. Liang K.-Y., Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986, 73:13-22.
21. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. NEngl J Med 2002, 346:1845-1853.
22. Kannel W.B., D'Agostino R.B., Silbershatz H., Belanger A.J., Wilson P.W., Levy D. Profile for estimating risk of heart failure. Arch Intern Med 1999, 159:1197-1204.
23. Lee D.S., Austin P.C., Rouleau J.L., Liu P.P., Naimark D., Tu J.V. Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003, 290:2581-2587.
24. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 2006, 113:1424-1433.
25. Peterson P.N., Rumsfeld J.S., Liang L., et al. Avalidated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. Circulation Cardiovasc Qual Outcomes 2010, 3:25-32.
26. Chaudhry S.I., Wang Y., Concato J., Gill T.M., Krumholz H.M. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007, 116:1549-1554.
27. Small R.S. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic. Am J Cardiol 2007, 99:17G-22G. Epub 2007 Mar 9.
28. Small R.S., Wickemeyer W., Germany R., et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. JCard Fail 2009, 15:475-481.
29. Abraham W.T., Adamson P.B., Bourge R.C., et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011, 377:658-666.
30. Bourge R.C., Abraham W.T., Adamson P.B., et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. JAm Coll Cardiol 2008, 51:1073-1079.
31. Cleland J.G., Louis A.A., Rigby A.S., Janssens U., Balk A.H. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. JAm Coll Cardiol 2005, 45:1654-1664. TEN-HMS Investigators.
32. Jaarsma T., van der Wal M.H., Lesman-Leegte I., et al. Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med 2008, 168:316-324.
33. Chaudhry S.I., Mattera J.A., Curtis J.P., et al. Telemonitoring in patients with heart failure. NEngl J Med 2010, 363:2301-2309.
34. Koehler F., Winkler S., Schieber M., et al. Telemedicine in heart failure: pre-specified and exploratory subgroup analyses from the TIM-HF trial. Int J Cardiol 2012, 161:143-150. Epub Oct 8. 10.1016/j.ijcard.2011.09.007.
35. Crandall M.A., Horne B.D., Day J.D., et al. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors. Pacing Clin Electrophysiol 2009, 32:981-986.
36. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001, 285:2864-2870.
37. van Veldhuisen D.J., Braunschweig F., Conraads V., et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011, 124:1719-1726.
38. Samara M.A., Tang W.H. Device monitoring strategies in acute heart failure syndromes. Heart Fail Rev 2011, 16:491-502.
39. Dierckx R., Houben R., Goethals M., et al. Integration of remote monitoring of device diagnostic parameters into a multidisciplinary heart failure management program. Int J Cardiol 2014, 172:606-607.
40. Crossley G.H., Boyle A., Vitense H., Chang Y., Mead R.H. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. JAm Coll Cardiol 2011, 57:1181-1189.
41. Boriani G., Da Costa A., Ricci R.P., et al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring. JMed Internet Res 2013, 15:e167.